Krystal Biotech KRYS 深 滬
等待開盤 09-23 09:30:00 美东时间
350.88
+17.030
+5.10%
華盛通- 最 高353.83
- 今 開334.76
- 成交量 27.46万股
- 最 低 334.31
- 昨 收 333.85
- 總市值 103.86亿
- 52周最高 382.535
- 市盈率 靜 51.31
- 換手率 0.93%
- 52周最低 179.19
- 委 比 0.00%
- 總股本 2959.88万
- 歷史最高 382.535
- 量 比 0.70
- 振 幅 5.85%
- 歷史最低 8.03
- 每 手 1
- 風險率 56.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
B of A Securities Maintains Buy on Krystal Biotech, Raises Price Target to $400
B of A Securities analyst Alec Stranahan maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $392 to $400.
09-22 01:41
Small-cap bears were back. Was IWM the warning sign?
The put-call ratio for the iShares Russell 2000 ETF (IWM) surged to 3.58, with Barchart saying the reading marked the highest level since April 2024. The ratio had climbed sharply in the latest readin...
09-02 23:29
Here’s How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 32.97% on an annualized basis producing an average annual return of 44.08%. Currently, Krystal Biotech has a market capitalization of $10.41 billion. Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5...
08-26 07:15
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
美股夜盘 | ERock劲升11.42%，Keel Infrastructure Corp.大升6.55%
ERock劲升11.42%；Keel Infrastructure Corp.大升6.55%；Marex Group上升5.21%
08-17 10:01
美股夜盘 | ERock大升8.31%，Keel Infrastructure Corp.大升7.69%
ERock大升8.31%；Keel Infrastructure Corp.大升7.69%；Marex Group大升5.21%
08-17 09:01
RBC Capital Initiates Coverage On Krystal Biotech with Outperform Rating, Announces Price Target of $400
RBC Capital analyst Lisa Walter initiates coverage on Krystal Biotech (NASDAQ:KRYS) with a Outperform rating and announces Price Target of $400.
08-14 22:15
